Single nucleotide polymorphism markers for low-dose aspirin-associated peptic ulcer and ulcer bleeding

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue S4, 2014, Pages 47-52

  Shiotani, Akiko ^a   Murao, Takahisa ^a   Fujita, Yoshihiko ^c   Fujimura, Yoshinori ^b   Sakakibara, Takashi ^b   Nishio, Kazuto ^c   Haruma, Ken ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b THE SAKAKIBARA HEART INSTITUTE OF OKAYAMA   (Japan)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin type 1 receptor (AT1R) blockers (ARBs); CHST2; DMET; HMG Co A reductase inhibitors (statins); SLCO1B

Indexed keywords

ACETYLSALICYLIC ACID; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1B1; ANTITHROMBOCYTIC AGENT; CARBOHYDRATE SULFOTRANSFERASES; ORGANIC ANION TRANSPORTER; SLCO1B1 PROTEIN, HUMAN; SULFOTRANSFERASE;

ADULT; AGED; ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; HAPLOTYPE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PEPTIC ULCER BLEEDING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMALL INTESTINE; VERY ELDERLY; ALLELE; CHEMICALLY INDUCED; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; QUESTIONNAIRE; RISK;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ASPIRIN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; ORGANIC ANION TRANSPORTERS; PEPTIC ULCER; PEPTIC ULCER HEMORRHAGE; PLATELET AGGREGATION INHIBITORS; POLYMORPHISM, SINGLE NUCLEOTIDE; QUESTIONNAIRES; RISK; SULFOTRANSFERASES;

EID: 84919413913     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12770     Document Type: Article

References (37)

1. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. II: maintenance of vascular graft or arterial patency by antiplatelet therapy. BMJ 1994; 308: 159-168.
2. Awtry EH, Loscalzo J. Aspirin. Circulation 2000; 101: 1206-1218.
3. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86.
4. Dai X, Makaryus AN, Makaryus JN, Jauhar R. Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis. Rev. Cardiovasc. Med. 2009; 10: 14-24.
5. Tan VP, Yan BP, Kiernan TJ, Ajani AE. Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention. Cardiovasc. Revasc. Med. 2009; 10: 36-44.
6. Shiotani A, Sakakibara T, Yamanaka Y etal. The preventive factors for aspirin-induced peptic ulcer: aspirin ulcer and corpus atrophy. J. Gastroenterol. 2009; 44: 717-725.
7. Shiotani A, Nishi R, Yamanaka Y etal. Renin-angiotensin system associated with risk of upper GI mucosal injury induced by low dose aspirin: renin angiotensin system genes' polymorphism. Dig. Dis. Sci. 2011; 56: 465-471.
8. Shiotani A, Murao T, Sakakibara T etal. Association of SLCO1B1 1b with peptic ulcer amongst Japanese patients taking low-dose aspirin. Dig. Liver Dis. 2012; 44: 201-205.
9. Cryer B, Feldman M. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterology 1999; 117: 17-25.
10. Hernandez LA, Grisham MB, Twohig B, Arfors KE, Harlan JM, Granger DN. Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am. J. Physiol. 1987; 253: H699-703.
11. McCafferty DM, Granger DN, Wallace JL. Indomethacin-induced gastric injury and leukocyte adherence in arthritic versus healthy rats. Gastroenterology 1995; 109: 1173-1180.
12. Santucci L, Fiorucci S, Giansanti M, Brunori PM, Di Matteo FM, Morelli A. Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumour necrosis factor alpha. Gut 1994; 35: 909-915.
13. Scalia R, Gooszen ME, Jones SP etal. Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice. Circulation 2001; 103: 2598-2603.
14. Tariq M, Khan HA, Elfaki I etal. Gastric antisecretory and antiulcer effects of simvastatin in rats. J. Gastroenterol. Hepatol. 2007; 22: 2316-2323.
15. Kameyama Y, Yamashita K, Kobayashi K, Hosokawa M, Chiba K. Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells. Pharmacogenet. Genomics 2005; 15: 513-522.
16. Niemi M, Pasanen MK, Neuvonen PJ. SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin. Clin. Pharmacol. Ther. 2006; 80: 356-366.
17. Pasanen MK, Backman JT, Neuvonen PJ, Niemi M. Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish population. Eur. J. Clin. Pharmacol. 2006; 62: 409-415.
18. Pasanen MK, Fredrikson H, Neuvonen PJ, Niemi M. Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin. Clin. Pharmacol. Ther. 2007; 82: 726-733.
19. Shiotani A, Sakakibara T, Yamanaka Y etal. Upper gastrointestinal ulcer in Japanese patients taking low-dose aspirin. J. Gastroenterol. 2009; 44: 126-131.
20. Shiotani A, Sakakibara T, Nomura M etal. Aspirin-induced peptic ulcer and genetic polymorphisms. J. Gastroenterol. Hepatol. 2010; 25 (Suppl. 1): S31-34.
21. van Oijen MG, Laheij RJ, Koetsier M etal. Effect of a specific cyclooxygenase-gene polymorphism (A-842G/C50T) on the occurrence of peptic ulcer hemorrhage. Dig. Dis. Sci. 2006; 51: 2348-2352.
22. Shiotani A, Murao T, Fujita Y etal. Novel single nucleotide polymorphism markers for low dose aspirin-associated small bowel bleeding. PLoS ONE 2013; 8: e84244.
23. Niemi M, Schaeffeler E, Lang T etal. High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1). Pharmacogenetics 2004; 14: 429-440.
24. Maeda K, Sugiyama Y. Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs. Drug Metab. Pharmacokinet. 2008; 23: 223-235.
25. Tirona RG, Leake BF, Merino G, Kim RB. Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans. J. Biol. Chem. 2001; 276: 35669-35675.
26. Tirona RG, Leake BF, Wolkoff AW, Kim RB. Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation. J. Pharmacol. Exp. Ther. 2003; 304: 223-228.
27. Nozawa T, Minami H, Sugiura S, Tsuji A, Tamai I. Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms. Drug Metab. Dispos. 2005; 33: 434-439.
28. Nishizato Y, Ieiri I, Suzuki H etal. Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics. Clin. Pharmacol. Ther. 2003; 73: 554-565.
29. Niemi M, Neuvonen PJ, Hofmann U etal. Acute effects of pravastatin on cholesterol synthesis are associated with SLCO1B1 (encoding OATP1B1) haplotype *17. Pharmacogenet. Genomics 2005; 15: 303-309.
30. SEARCH Collaborative Group, Link E, Parish S, Armitage J etal. SLCO1B1 variants and statin-induced myopathy: a genome-wide study. N. Engl. J. Med. 2008; 359: 789-799.
31. Kivisto KT, Niemi M. Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans. Pharm. Res. 2007; 24: 239-247.
32. Nozawa T, Nakajima M, Tamai I etal. Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis. J. Pharmacol. Exp. Ther. 2002; 302: 804-813.
33. Mwinyi J, Johne A, Bauer S, Roots I, Gerloff T. Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics. Clin. Pharmacol. Ther. 2004; 75: 415-421.
34. Fukuda M, Hiraoka N, Akama TO, Fukuda MN. Carbohydrate-modifying sulfotransferases: structure, function, and pathophysiology. J. Biol. Chem. 2001; 276: 47747-47750.
35. Bistrup A, Bhakta S, Lee JK etal. Sulfotransferases of two specificities function in the reconstitution of high endothelial cell ligands for L-selectin. J. Cell Biol. 1999; 145: 899-910.
36. Yeh JC, Hiraoka N, Petryniak B etal. Novel sulfated lymphocyte homing receptors and their control by a Core1 extension beta 1, 3-N-acetylglucosaminyltransferase. Cell 2001; 105: 957-969.
37. Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ 2000; 321: 1183-1187.